Wavu Wank

TEKKEN® 8 glicko2 Ratings &
Online Ranked Statistics

Ratings

MedKenobi vs Jin 95–105 47.50%
MedKenobi vs Kazuya 98–95 50.78%
MedKenobi vs Hwoarang 69–81 46.00%
MedKenobi vs King 62–60 50.82%
MedKenobi vs Law 56–57 49.56%
MedKenobi vs Reina 61–48 55.96%
MedKenobi vs Steve 59–48 55.14%
MedKenobi vs Heihachi 57–50 53.27%
MedKenobi vs Bryan 51–46 52.58%
MedKenobi vs Eddy 46–48 48.94%
MedKenobi vs Paul 36–43 45.57%
MedKenobi vs Lili 46–32 58.97%
MedKenobi vs Dragunov 43–35 55.13%
MedKenobi vs Nina 49–28 63.64%
MedKenobi vs Yoshimitsu 32–32 50.00%
MedKenobi vs Devil Jin 32–29 52.46%
MedKenobi vs Alisa 35–21 62.50%
MedKenobi vs Asuka 34–21 61.82%
MedKenobi vs Azucena 23–32 41.82%
MedKenobi vs Jun 30–24 55.56%
MedKenobi vs Xiaoyu 26–26 50.00%
MedKenobi vs Lars 26–22 54.17%
MedKenobi vs Anna 32–16 66.67%
MedKenobi vs Lee 9–32 21.95%
MedKenobi vs Victor 20–20 50.00%
MedKenobi vs Feng 10–20 33.33%
MedKenobi vs Clive 13–16 44.83%
MedKenobi vs Lidia 15–13 53.57%
MedKenobi vs Leroy 15–9 62.50%
MedKenobi vs Leo 11–12 47.83%
MedKenobi vs Raven 10–12 45.45%
MedKenobi vs Jack-8 10–11 47.62%
MedKenobi vs Zafina 11–10 52.38%
MedKenobi vs Kuma 9–11 45.00%
MedKenobi vs Claudio 7–11 38.89%
MedKenobi vs Fahkumram 12–6 66.67%
MedKenobi vs Armor King 5–6 45.45%
MedKenobi vs Shaheen 3–5 37.50%
MedKenobi vs Panda 4–2 66.67%
MedKenobi vs Miary Zo 1–0 100.00%

Limitations

This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.

For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.

There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.

In the meantime, this page is here to present the data as requested.